The Oncotype DX Colon Recurrence Score test is covered by Medicare, and private insurance coverage varies. We assist you through the claims process with your insurance company, including with your permission, help with appeals for any denial of coverage
financial responsibility for Oncotype DX Colon Recurrence Score test when Medicare fee for service (FFS) coverage criteria are met
Medicare Advantage, which is provided by commercial insurance companies, may have different financial responsibility compared to Medicare FFS.
Genomic Access Program
Exact Sciences believes that everyone should have access to the information they need to make confident, informed decisions about their cancer treatments. To ensure you can focus on your health, Exact Sciences created the Genomic Access Program (GAP), which helps you determine payment options for our tests. We work with providers, patients, and insurance companies to investigate coverage and complete any prior authorization requirements, where applicable.
If you have insurance, Exact Sciences will bill your insurance once testing is complete. In the event your insurance denies payment, Exact Sciences may contact you to complete a consent form that allows us to pursue an appeal on your behalf. If you don’t have insurance, our Customer Service team is available to help you manage the cost of testing.
Download the GAP Brochure
Download in other languages: Spanish | Traditional Chinese | Simplified Chinese
To discuss our flexible payment options, your extenuating financial circumstances, or to be pre-screened for financial assistance, contact Customer Service by phone at ( 866-ONCOTYPE866-662-6897, option 2) or message us for more information.
Exact Sciences offers financial assistance for eligible patients based on the Federal poverty guidelines. If eligible, both insured and uninsured patients will have no out-of-pocket costs.
For more information, see our FAQs.